BO9068776401
Boron Molecular
2-(tert-Butylcarbonylamino)phenylboronic acid, pinacol ester
About This Item
推荐产品
Iupac Name
2,2-dimethyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide
Inchi Code
1S/C17H26BNO3/c1-15(2,3)14(20)19-13-11-9-8-10-12(13)18-21-16(4,5)17(6,7)22-18/h8-11H,1-7H3,(H,19,20)
InChI key
RRMWKQYLEOBFNW-UHFFFAOYSA-N
1 of 4
此商品 | 103795 | 14390C | 103796 |
---|---|---|---|
technique(s) cell culture | mammalian: suitable (suspension) | technique(s) cell culture | mammalian: suitable (suspension) | technique(s) cell culture | mammalian: suitable (suspension) | technique(s) cell culture | mammalian: suitable (suspension) |
form dry powder | form dry powder | form liquid | form dry powder |
storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
product line Cellvento® | product line Cellvento® | product line Cellvento® | product line Cellvento® |
description shipped with cooling packs | description shipped with cooling packs | description - | description shipped with cooling packs |
Quality Level 500 | Quality Level 500 | Quality Level - | Quality Level 500 |
Purity
Country of Origin
Product Link
MSDS
https://www.boronmolecular.com/catalogue/BM134
法规信息
其他客户在看
商品
This page describes the design attributes of the Cellicon® filter assembly for cell retention and how they simplify scale-up of intensified upstream processes.
This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.
High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.
Cell culture media are vital for bioprocessing therapeutics. This page describes the central role of our organization in authoring purpose-built GMP for cell culture media.
相关内容
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
This page describes the use of a small-scale perfusion bioreactor with integrated microfluidic flow control and sensor technologies to predict large-scale processes.
Learn more about cell culture media development for mAB development and manufacturing, and the products you need for this step.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持